Harbin Pharmaceutical Group Co., Ltd. (SHA:600664)

China · Delayed Price · Currency is CNY

7.50

+0.08 (1.08%)

Sep 18, 2026, 3:00 PM CST

SHA:600664 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	16,135	15,964	16,176	15,457	13,809	12,802
Revenue Growth	-0.14%	-1.31%	4.65%	11.93%	7.86%	18.66%
Gross Profit	4,104	4,114	4,521	4,013	3,363	2,976
Operating Income	669.57	572.25	849.71	618.44	557.91	447.79
Net Income	512.21	361.6	628.85	395.26	465.15	371.08
Earnings Per Share	0.20	0.14	0.25	0.16	0.18	0.15
EPS Growth	-7.29%	-44.00%	56.25%	-11.11%	20.00%	-

Revenue by Segment

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Industrial	5,741
Business Tips	10,339
Interdepartmental Offset	-179.83
Total	15,901

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	3,385	3,437	3,634	3,060	2,433	1,592
Total Debt	1,307	1,236	1,762	1,857	2,149	2,313
Net Cash (Debt)	2,078	2,201	1,872	1,203	284.1	-720.94
Net Cash Growth	19.00%	17.58%	55.56%	323.57%	-	-
Net Cash Per Share	0.80	0.85	0.74	0.49	0.11	-0.29

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	534.63	439.66	792.5	949.67	622.09	-162.44
Capital Expenditures	-174.36	-150.95	-100.81	-86.54	-89.65	-76.7
Free Cash Flow	360.27	288.71	691.69	863.14	532.45	-239.13
Free Cash Flow Growth	-22.87%	-58.26%	-19.86%	62.11%	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	25.44%	25.77%	27.95%	25.96%	24.35%	23.24%
Operating Margin	4.15%	3.58%	5.25%	4.00%	4.04%	3.50%
Pretax Margin	4.52%	3.59%	5.41%	4.21%	5.08%	4.93%
Profit Margin	3.17%	2.27%	3.89%	2.56%	3.37%	2.90%
FCF Margin	2.23%	1.81%	4.28%	5.58%	3.86%	-1.87%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	37.82	24.03	16.54	21.37	16.34	24.09
Forward PE	31.25	12.32	12.48	12.48	12.48	12.48
P/FCF Ratio	52.43	30.10	15.04	9.78	14.27	-
PS Ratio	1.17	0.54	0.64	0.55	0.55	0.70